.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
Chubb
Dow
Mallinckrodt
Daiichi Sankyo
Moodys
Johnson and Johnson
McKinsey
US Department of Justice

Generated: December 17, 2017

DrugPatentWatch Database Preview

Chemo Research Sl Company Profile

« Back to Dashboard

What is the competitive landscape for CHEMO RESEARCH SL, and when can generic versions of CHEMO RESEARCH SL drugs launch?

CHEMO RESEARCH SL has three approved drugs.

There are six US patents protecting CHEMO RESEARCH SL drugs.

There are thirty-one patent family members on CHEMO RESEARCH SL drugs in seventeen countries and one supplementary protection certificate in one country.

Summary for Chemo Research Sl

International Patents:31
US Patents:6
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chemo Research SlBENZNIDAZOLEbenznidazoleTABLET;ORAL209570-001Aug 29, 2017RXYesNo► Subscribe► Subscribe► Subscribe
Chemo Research SlBENZNIDAZOLEbenznidazoleTABLET;ORAL209570-002Aug 29, 2017RXYesYes► Subscribe► Subscribe► Subscribe
Chemo Research SlNUVESSAmetronidazoleGEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Chemo Research SlNUVESSAmetronidazoleGEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Chemo Research SlNUVESSAmetronidazoleGEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Chemo Research SlECOZAeconazole nitrateAEROSOL, FOAM;TOPICAL205175-001Oct 24, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Chemo Research SlNUVESSAmetronidazoleGEL;VAGINAL205223-001Mar 24, 2014RXYesYes► Subscribe► SubscribeY► Subscribe
Chemo Research SlBENZNIDAZOLEbenznidazoleTABLET;ORAL209570-002Aug 29, 2017RXYesYes► Subscribe► Subscribe► Subscribe
Chemo Research SlBENZNIDAZOLEbenznidazoleTABLET;ORAL209570-001Aug 29, 2017RXYesNo► Subscribe► Subscribe► Subscribe
Chemo Research SlECOZAeconazole nitrateAEROSOL, FOAM;TOPICAL205175-001Oct 24, 2013RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Chemo Research Sl Drugs

Country Document Number Estimated Expiration
China103763925► Subscribe
Australia2012275292► Subscribe
Norway993201► Subscribe
Australia2016200825► Subscribe
Japan5986632► Subscribe
Sweden9700129► Subscribe
Portugal961610► Subscribe
European Patent Office2725904► Subscribe
Sweden520811► Subscribe
China1243431► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Chemo Research Sl Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0021Belgium► SubscribePRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Fuji
AstraZeneca
Federal Trade Commission
Merck
Colorcon
QuintilesIMS
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot